- Home
- ROIV vs EAT Comparison
ROIV vs EAT Comparison
Compare ROIV & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | EAT |
|---|---|---|
| Founded | 2014 | 1975 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 5.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | EAT |
|---|---|---|
| Price | $22.39 | $150.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $24.31 | ★ $165.00 |
| AVG Volume (30 Days) | ★ 7.9M | 1.5M |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 136.76 |
| EPS | N/A | ★ 9.64 |
| Revenue | $20,329,000.00 | ★ $5,594,400,000.00 |
| Revenue This Year | N/A | $7.80 |
| Revenue Next Year | $376.94 | $5.17 |
| P/E Ratio | ★ N/A | $15.61 |
| Revenue Growth | N/A | ★ 23.18 |
| 52 Week Low | $8.73 | $100.30 |
| 52 Week High | $23.47 | $192.22 |
Technical Indicators
Market Signals| Indicator | ROIV | EAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.35 | 65.02 |
| Support Level | $21.60 | $143.52 |
| Resistance Level | $23.47 | $154.83 |
| Average True Range (ATR) | 0.88 | 6.46 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 72.79 | 80.27 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.